Ann G. Zauber

39.4k total citations · 15 hit papers
250 papers, 26.0k citations indexed

About

Ann G. Zauber is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Ann G. Zauber has authored 250 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 105 papers in Pulmonary and Respiratory Medicine and 79 papers in Pathology and Forensic Medicine. Recurrent topics in Ann G. Zauber's work include Colorectal Cancer Screening and Detection (166 papers), Gastric Cancer Management and Outcomes (99 papers) and Genetic factors in colorectal cancer (74 papers). Ann G. Zauber is often cited by papers focused on Colorectal Cancer Screening and Detection (166 papers), Gastric Cancer Management and Outcomes (99 papers) and Genetic factors in colorectal cancer (74 papers). Ann G. Zauber collaborates with scholars based in United States, Netherlands and United Kingdom. Ann G. Zauber's co-authors include Sidney J. Winawer, Iris Lansdorp‐Vogelaar, Marjolein van Ballegooijen, Michael J. O’Brien, John H. Bond, Jerome D. Waye, Edward T. Stewart, Melvin Schapiro, Joel F. Panish and Leonard S. Gottlieb and has published in prestigious journals such as Nature, New England Journal of Medicine and JAMA.

In The Last Decade

Ann G. Zauber

243 papers receiving 25.2k citations

Hit Papers

Prevention of Colorectal Cancer by Colonoscopic Polypectomy 1990 2026 2002 2014 1993 2012 2005 2009 2014 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention of Colorectal Cancer by Colonoscopic Polypectomy
    1993 3.4k citations Sidney J. Winawer, Ann G. Zauber et al. profile →
  2. Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
    2012 2.2k citations Ann G. Zauber, Sidney J. Winawer et al. profile →
  3. Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
    2005 1.6k citations Ann G. Zauber, Ernest T. Hawk et al. profile →
  4. Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
    2009 1.5k citations Ann G. Zauber, Ahmedin Jemal et al. profile →
  5. Adenoma Detection Rate and Risk of Colorectal Cancer and Death
    2014 1.5k citations Douglas A. Corley, Christopher D. Jensen et al. profile →
  6. Celecoxib for the Prevention of Colorectal Adenomatous Polyps
    2006 751 citations Craig Eagle, Ann G. Zauber et al. profile →
  7. Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps
    1993 734 citations Sidney J. Winawer, Ann G. Zauber et al. profile →
  8. The National Polyp Study
    1990 613 citations Ann G. Zauber et al. Gastroenterology profile →
  9. Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
    2006 551 citations Sidney J. Winawer, Ann G. Zauber et al. Gastroenterology profile →
  10. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population
    2018 339 citations Theodore R. Levin, Douglas A. Corley et al. Gastroenterology profile →
  11. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women
    2018 337 citations Ann G. Zauber, Andrew T. Chan et al. profile →
  12. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies
    2016 335 citations Amy B. Knudsen, Ann G. Zauber et al. profile →
  13. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study
    2016 305 citations Chyke A. Doubeni, Douglas A. Corley et al. profile →
  14. Colorectal Cancer Screening
    2021 186 citations Amy B. Knudsen, Carolyn M. Rutter et al. profile →
  15. Young-onset colorectal cancer
    2023 133 citations Manon C.W. Spaander, Ann G. Zauber et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann G. Zauber United States 68 19.7k 12.5k 7.4k 5.6k 2.5k 250 26.0k
Francis M. Giardiello United States 66 13.6k 0.7× 6.2k 0.5× 10.3k 1.4× 5.5k 1.0× 1.6k 0.6× 181 23.3k
Richard M. Goldberg United States 85 24.0k 1.2× 8.3k 0.7× 9.7k 1.3× 6.9k 1.2× 504 0.2× 531 33.3k
Jeffrey A. Meyerhardt United States 85 16.3k 0.8× 4.3k 0.3× 5.4k 0.7× 3.3k 0.6× 750 0.3× 431 25.8k
Richard L. Schilsky United States 75 13.8k 0.7× 6.0k 0.5× 3.2k 0.4× 2.3k 0.4× 885 0.3× 382 23.2k
Randall W. Burt United States 55 11.5k 0.6× 4.8k 0.4× 10.5k 1.4× 3.4k 0.6× 760 0.3× 193 17.7k
John H. Bond United States 47 18.8k 1.0× 13.3k 1.1× 8.0k 1.1× 5.1k 0.9× 306 0.1× 119 23.2k
William F. Anderson United States 55 8.9k 0.5× 3.9k 0.3× 2.6k 0.4× 4.6k 0.8× 1.3k 0.5× 134 21.6k
Aimery de Gramont France 64 20.1k 1.0× 6.8k 0.5× 4.4k 0.6× 5.3k 0.9× 365 0.1× 333 25.0k
Sidney J. Winawer United States 59 20.0k 1.0× 12.9k 1.0× 8.5k 1.2× 5.6k 1.0× 259 0.1× 225 24.4k
Leonard B. Saltz United States 105 28.0k 1.4× 9.6k 0.8× 6.0k 0.8× 10.3k 1.8× 452 0.2× 544 38.3k

Countries citing papers authored by Ann G. Zauber

Since Specialization
Citations

This map shows the geographic impact of Ann G. Zauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann G. Zauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann G. Zauber more than expected).

Fields of papers citing papers by Ann G. Zauber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann G. Zauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann G. Zauber. The network helps show where Ann G. Zauber may publish in the future.

Co-authorship network of co-authors of Ann G. Zauber

This figure shows the co-authorship network connecting the top 25 collaborators of Ann G. Zauber. A scholar is included among the top collaborators of Ann G. Zauber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann G. Zauber. Ann G. Zauber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knudsen, Amy B., Daan Nieboer, Karen M. Kuntz, et al.. (2025). Benefits of colorectal cancer screening using fecal immunochemical testing with varying positivity thresholds by age and sex. JNCI Journal of the National Cancer Institute. 117(11). 2219–2228.
2.
Lima, Pedro Nascimento de, Amy B. Knudsen, Karen M. Kuntz, et al.. (2024). Characteristics of a cost-effective blood test for colorectal cancer screening. JNCI Journal of the National Cancer Institute. 116(10). 1612–1620. 10 indexed citations
3.
Huang, Robert J., Margaret Zhou, John D. Murphy, et al.. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 22(8). 1605–1617.e46. 18 indexed citations
4.
Shi, Kewei Sylvia, Robert L. Smith, Jingxuan Zhao, et al.. (2024). Implications of the initial Braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study. JNCI Journal of the National Cancer Institute. 117(4). 790–794. 1 indexed citations
5.
Laszkowska, Monika, et al.. (2024). 230 GLOBAL BURDEN OF YOUNG-ONSET GASTRIC CANCER: A SYSTEMATIC TREND ANALYSIS OF THE GLOBAL BURDEN OF DISEASE STUDY 2019. Gastroenterology. 166(5). S–50. 1 indexed citations
6.
Spaander, Manon C.W., Ann G. Zauber, Sapna Syngal, et al.. (2023). Young-onset colorectal cancer. Nature Reviews Disease Primers. 9(1). 21–21. 133 indexed citations breakdown →
7.
Knudsen, Amy B., Amy Trentham‐Dietz, Jane J. Kim, et al.. (2023). Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening. JAMA Network Open. 6(11). e2344698–e2344698. 24 indexed citations
8.
Lui, Thomas Ka-Luen, Kevin Sze-Hang Liu, Kathy Leung, et al.. (2023). The Impacts of Computer-Aided Detection of Colorectal Polyps on Subsequent Colonoscopy Surveillance Intervals: Simulation Study. Journal of Medical Internet Research. 25. e42665–e42665. 2 indexed citations
9.
McFerran, Ethna, James F. O’Mahony, Steffie K. Naber, et al.. (2022). Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?. MDM Policy & Practice. 7(1). 97843816–97843816. 6 indexed citations
10.
Lansdorp‐Vogelaar, Iris, et al.. (2022). Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis. Cancer Epidemiology Biomarkers & Prevention. 32(1). 22–29. 16 indexed citations
11.
Peterse, Elisabeth F.P., Reinier G.S. Meester, Lucie de Jonge, et al.. (2020). Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests. JNCI Journal of the National Cancer Institute. 113(2). 154–161. 65 indexed citations
12.
Lee, Jeffrey K., Christopher D. Jensen, Theodore R. Levin, et al.. (2019). Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 158(4). 884–894.e5. 93 indexed citations
13.
Cunniff, Christopher, Bernard Cohen, Nathan A. Ellis, et al.. (2018). Health supervision for people with Bloom syndrome. American Journal of Medical Genetics Part A. 176(9). 1872–1881. 33 indexed citations
14.
Hees, Frank van, J. Dik F. Habbema, Reinier G.S. Meester, et al.. (2014). Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening. Annals of Internal Medicine. 4 indexed citations
15.
Wang, Jiping, Luis G. Carvajal‐Carmona, J Chu, et al.. (2013). Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study. Clinical Cancer Research. 19(23). 6430–6437. 8 indexed citations
16.
Lansdorp‐Vogelaar, Iris, Karen M. Kuntz, Amy B. Knudsen, et al.. (2012). Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiology Biomarkers & Prevention. 21(5). 728–736. 167 indexed citations
17.
Chan, Andrew T., Camelia S. Sima, Ann G. Zauber, et al.. (2011). C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment. Cancer Prevention Research. 4(8). 1172–1180. 18 indexed citations
18.
Chan, Andrew T., Meier Hsu, Ann G. Zauber, Ernest T. Hawk, & Monica M. Bertagnolli. (2011). The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma. Cancer Prevention Research. 5(1). 61–72. 13 indexed citations
19.
Cho, Nancy L., Mark Redston, Ann G. Zauber, et al.. (2008). Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial. Cancer Prevention Research. 1(1). 21–31. 46 indexed citations
20.
Martı́nez, Marı́a Elena, John A. Baron, David A. Lieberman, et al.. (2008). A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy. Gastroenterology. 136(3). 832–841. 413 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis M. Giardiello Breakdown of academic impact, for papers by Richard M. Goldberg Breakdown of academic impact, for papers by Jeffrey A. Meyerhardt Breakdown of academic impact, for papers by Richard L. Schilsky Breakdown of academic impact, for papers by Randall W. Burt Breakdown of academic impact, for papers by John H. Bond Breakdown of academic impact, for papers by William F. Anderson Breakdown of academic impact, for papers by Aimery de Gramont Breakdown of academic impact, for papers by Sidney J. Winawer Breakdown of academic impact, for papers by Leonard B. Saltz
Rankless by CCL
2026